Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Artificial Intelligence in Predicting Stage and Survival in Non-Small Cell Lung Cancer

NCT07068139 is registered in ClinicalTrials.gov with Hilkat Fatih Elverdi as lead sponsor.

NCT NCT07068139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07068139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Artificial Intelligence in Predicting Stage and Survival in Non-Small Cell Lung Cancer
Lead sponsor
Hilkat Fatih Elverdi
Phase
Observational
Overall status
Completed
Start date
January 1, 2010
Completion date
June 1, 2026
Enrollment
156 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence (ai) in diagnosis, non-small cell lung cancer